Hematopoietic Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousStem Cell TransplantationStem CellsTransplantation, AutologousTransplantation ConditioningGraft vs Host DiseasePeripheral Blood Stem Cell TransplantationHematologic NeoplasmsBone Marrow TransplantationTransplantation ChimeraAntigens, CD34HematopoiesisTissue DonorsCell DifferentiationHematopoietic Stem Cell MobilizationTreatment OutcomeCord Blood Stem Cell TransplantationGraft SurvivalBone Marrow CellsWhole-Body IrradiationHistocompatibility TestingMyeloablative AgonistsBusulfanCell LineageHistocompatibilityLeukemiaChimerismGraft vs Leukemia EffectRetrospective StudiesLiver TransplantationRecurrenceColony-Forming Units AssayAdult Stem CellsFlow CytometryMice, Inbred C57BLMesenchymal Stem Cell TransplantationEmbryonic Stem CellsBone MarrowStem Cell NicheHematologic DiseasesTime FactorsCell TransplantationImmunosuppressive AgentsRemission InductionCombined Modality TherapyCells, CulturedMultiple MyelomaLeukemia, Myeloid, AcuteFetal BloodHepatic Veno-Occlusive DiseaseHLA AntigensMyelodysplastic SyndromesSiblingsGranulocyte Colony-Stimulating FactorVidarabineUnrelated DonorsCell ProliferationSurvival RateGraft vs Tumor EffectDisease-Free SurvivalNeural Stem CellsMultipotent Stem CellsMelphalanCell SeparationTransplantation ImmunologySurvival AnalysisSevere Combined ImmunodeficiencyKidney TransplantationLymphocyte TransfusionCyclophosphamideStem Cell FactorMesenchymal Stromal CellsTransplantation, IsogeneicMyeloid Progenitor CellsLeukemia, Myelogenous, Chronic, BCR-ABL PositivePrecursor Cell Lymphoblastic Leukemia-LymphomaSalvage TherapyCytomegalovirus InfectionsAnemia, AplasticT-LymphocytesAntilymphocyte SerumFetal Stem CellsDonor SelectionAntineoplastic Combined Chemotherapy ProtocolsLymphocyte DepletionFollow-Up StudiesAcute DiseaseAllograftsMice, SCIDPluripotent Stem CellsCell Culture TechniquesGraft RejectionAntigens, CDRegenerationLymphoma, Non-HodgkinLymphopoiesisImmunosuppressionOpportunistic Infections